Clinical Trials Browser

Phase 1 × Neoplasms × lortalamine × Clear all

NCT00925275 2010-05-04

Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors

Phase 1 Completed

Neoplasms, Recurrence